These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 426067)

  • 21. [Diagnostic and therapeutic significance of inhibitors of the renin-angiotensin system].
    Stumpe KO; Kolloch RE; Redlich B; Vetter H; Krück F
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():167-76. PubMed ID: 613561
    [No Abstract]   [Full Text] [Related]  

  • 22. [des-Asp1]angiotensin II in the dog: blood levels and effect on aldosterone.
    Semple PF; Nicholls MG; Tree M; Fraser R
    Endocrinology; 1978 Oct; 103(4):1476-82. PubMed ID: 744159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stimulation of corticosteroid biosynthesis by angiotensin I [des-asp1]angiotensin I, angiotensin II and [des-asp1]-angiotensin II in bovine adrenal fasciculata cells.
    Hepp R; Grillet C; Peytremann A; Vallotton MB
    Endocrinology; 1977 Sep; 101(3):717-25. PubMed ID: 196831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of beta-adrenergic blockade and inhibitors of angiotensin II and prostaglandins on renal autoregulation.
    Anderson RJ; Taher MS; Cronin RE; McDonald KM; Schrier RW
    Am J Physiol; 1975 Sep; 229(3):731-6. PubMed ID: 813531
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Failure of high doses of Sar1-lle8-angiotensin II to abolish autoregulation of renal blood flow.
    Messick J; Spielman WS; Knox FG
    Mayo Clin Proc; 1980 Oct; 55(10):619-22. PubMed ID: 6997644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of angiotensin II antagonist infusion on autoregulation of renal blood flow.
    Abe Y; Kishimoto T; Yamamoto K
    Am J Physiol; 1976 Oct; 231(4):1267-71. PubMed ID: 984212
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intrarenal control of electrolyte excretion by angiotensin II.
    Hall JE; Guyton AC; Trippodo NC; Lohmeier TE; McCaa RE; Cowley AW
    Am J Physiol; 1977 Jun; 232(6):F538-44. PubMed ID: 879288
    [No Abstract]   [Full Text] [Related]  

  • 28. Characterization of immunoreactive angiotensin in canine cerebrospinal fluid as Des-Asp1-angiotensin II.
    Hutchinsón JS; Csicsmann J; Korner PI; Johnston CI
    Clin Sci Mol Med; 1978 Feb; 54(2):147-51. PubMed ID: 620503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of inhibition of peptidase activity on distribution of intrarenal blood flow.
    Bailie MD; Barbour JA
    Am J Physiol; 1975 Mar; 228(3):850-3. PubMed ID: 163595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Des-Asp1] angiotensin II: mediator of the renin-angiotensin system?
    Freeman RH; Davis JO; Lohmeier TE; Spielman WS
    Fed Proc; 1977 Apr; 36(5):1766-70. PubMed ID: 321257
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Action of angiotensin I converting enzyme inhibitor on the control of renal function in the cat.
    Johns EJ
    Clin Sci (Lond); 1979 Apr; 56(4):365-71. PubMed ID: 225092
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of an angiotensin II antagonist on autoregulation in the isolated dog kidney.
    Kaloyanides GJ; DiBona GF
    Am J Physiol; 1976 Apr; 230(4):1078-83. PubMed ID: 1267003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Converting enzyme inhibition and the kidney.
    Meggs LG; Hollenberg NK
    Hypertension; 1980; 2(4):551-7. PubMed ID: 6156899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of role of renin-angiotensin system in autoregulation of glomerular filtration.
    Gagnon JA; Keller HI; Kokotis W; Schrier RW
    Am J Physiol; 1970 Aug; 219(2):491-6. PubMed ID: 4317601
    [No Abstract]   [Full Text] [Related]  

  • 35. The pivotal role at angiotensin III in the brain angiotensin system.
    Harding JW; Felix D; Sullivan MJ; Camara CA; Erickson JB; Regulja I; Abhold RF; Wright JW
    Proc West Pharmacol Soc; 1987; 30():11-5. PubMed ID: 3628260
    [No Abstract]   [Full Text] [Related]  

  • 36. The role of intrarenal angiotensin II in the hemodynamic response to unilateral obstructive uropathy.
    Moody TE; Vaughan ED; Wyker AT; Gillenwater JY
    Invest Urol; 1977 Mar; 14(5):390-7. PubMed ID: 845004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and evaluation of (Des-Asp1)angiotensin I as a precursor for (Des-Asp1)angiotensin II ("Angiotensin III").
    Tsai BS; Peach MJ; Khosla MC; Bumpus FM
    J Med Chem; 1975 Dec; 18(12):1180-3. PubMed ID: 172631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Control of renal function by intrarenal angiotensin II.
    Levens NR; Freedlender AE; Peach MJ; Carey RM
    Endocrinology; 1983 Jan; 112(1):43-9. PubMed ID: 6847833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Editorial: Mechanisms in hypertension.
    Lancet; 1975 Sep; 2(7932):445. PubMed ID: 51247
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of endogenous angiotensin II on renal sodium excretion and renal hemodynamics.
    Lohmeier TE; Cowley AW; Trippodo NC; Hall JE; Guyton AC
    Am J Physiol; 1977 Nov; 233(5):F388-95. PubMed ID: 920808
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.